156 related articles for article (PubMed ID: 33001305)
21. Hepatocellular carcinoma: Can LI-RADS v2017 with gadoxetic-acid enhancement magnetic resonance and diffusion-weighted imaging improve diagnostic accuracy?
Zhang T; Huang ZX; Wei Y; Jiang HY; Chen J; Liu XJ; Cao LK; Duan T; He XP; Xia CC; Song B
World J Gastroenterol; 2019 Feb; 25(5):622-631. PubMed ID: 30774276
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic Accuracy of CEUS LI-RADS for the Characterization of Liver Nodules 20 mm or Smaller in Patients at Risk for Hepatocellular Carcinoma.
Huang JY; Li JW; Lu Q; Luo Y; Lin L; Shi YJ; Li T; Liu JB; Lyshchik A
Radiology; 2020 Feb; 294(2):329-339. PubMed ID: 31793849
[TBL] [Abstract][Full Text] [Related]
23. Identification of the origin of tumor in vein: comparison between CEUS LI-RADS v2017 and v2016 for patients at high risk.
Tong WJ; Cheng MQ; Lin MX; Hu HT; Pan JM; Huang H; Wang Y; Xie XY; Lu MD; Kuang M; Huang Y; Wang W
BMC Med Imaging; 2022 Oct; 22(1):186. PubMed ID: 36309665
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic accuracy of contrast-enhanced ultrasound for the differential diagnosis of hepatocellular carcinoma: ESCULAP versus CEUS-LI-RADS.
Schellhaas B; Görtz RS; Pfeifer L; Kielisch C; Neurath MF; Strobel D
Eur J Gastroenterol Hepatol; 2017 Sep; 29(9):1036-1044. PubMed ID: 28562394
[TBL] [Abstract][Full Text] [Related]
25. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
[TBL] [Abstract][Full Text] [Related]
26. LI-RADS for CT diagnosis of hepatocellular carcinoma: performance of major and ancillary features.
Alhasan A; Cerny M; Olivié D; Billiard JS; Bergeron C; Brown K; Bodson-Clermont P; Castel H; Turcotte S; Perreault P; Tang A
Abdom Radiol (NY); 2019 Feb; 44(2):517-528. PubMed ID: 30167771
[TBL] [Abstract][Full Text] [Related]
27. LI-RADS Tumor in Vein at CT and Hepatobiliary MRI.
Bae JS; Lee JM; Jeon SK; Yoo J; Park SJ; Yoon JH; Joo I; Lee KB; Kim H
Radiology; 2022 Jan; 302(1):107-115. PubMed ID: 34581625
[TBL] [Abstract][Full Text] [Related]
28. Validation of Liver Imaging Reporting and Data System 2017 (LI-RADS) Criteria for Imaging Diagnosis of Hepatocellular Carcinoma.
Kierans AS; Makkar J; Guniganti P; Cornman-Homonoff J; Lee MJ; Pittman M; Askin G; Hecht EM
J Magn Reson Imaging; 2019 Jun; 49(7):e205-e215. PubMed ID: 30257054
[TBL] [Abstract][Full Text] [Related]
29. Contrast-enhanced ultrasound LI-RADS 2017: comparison with CT/MRI LI-RADS.
Ding J; Long L; Zhang X; Chen C; Zhou H; Zhou Y; Wang Y; Jing X; Ye Z; Wang F
Eur Radiol; 2021 Feb; 31(2):847-854. PubMed ID: 32803416
[TBL] [Abstract][Full Text] [Related]
30. Interreader Agreement of Liver Imaging Reporting and Data System on MRI: A Systematic Review and Meta-Analysis.
Kang JH; Choi SH; Lee JS; Park SH; Kim KW; Kim SY; Lee SS; Byun JH
J Magn Reson Imaging; 2020 Sep; 52(3):795-804. PubMed ID: 31984578
[TBL] [Abstract][Full Text] [Related]
31. Inter-reader reliability of CT Liver Imaging Reporting and Data System according to imaging analysis methodology: a systematic review and meta-analysis.
Kang JH; Choi SH; Lee JS; Kim KW; Kim SY; Lee SS; Byun JH
Eur Radiol; 2021 Sep; 31(9):6856-6867. PubMed ID: 33713172
[TBL] [Abstract][Full Text] [Related]
32. Compared with SonoVue
Cao J; Wang H; Ling W
Quant Imaging Med Surg; 2024 Apr; 14(4):2978-2992. PubMed ID: 38617150
[TBL] [Abstract][Full Text] [Related]
33. LI-RADS LR-5 on contrast-enhanced ultrasonography has satisfactory diagnostic specificity for hepatocellular carcinoma: a systematic review and meta-analysis.
Jin H; Cai Y; Zhang M; Huang L; Bao W; Hu Q; Chen X; Zhou L; Ling W
Quant Imaging Med Surg; 2023 Feb; 13(2):957-969. PubMed ID: 36819240
[TBL] [Abstract][Full Text] [Related]
34. Non-invasive imaging criteria for the diagnosis of hepatocellular carcinoma in non-cirrhotic patients with chronic hepatitis B.
Moctezuma-Velázquez C; Lewis S; Lee K; Amodeo S; Llovet JM; Schwartz M; Abraldes JG; Villanueva A
JHEP Rep; 2021 Dec; 3(6):100364. PubMed ID: 34712933
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic accuracy of prospective application of the Liver Imaging Reporting and Data System (LI-RADS) in gadoxetate-enhanced MRI.
Kim YY; An C; Kim S; Kim MJ
Eur Radiol; 2018 May; 28(5):2038-2046. PubMed ID: 29230525
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic accuracy of Liver Imaging Reporting and Data System locoregional treatment response criteria: a systematic review and meta-analysis.
Gupta P; Bansal A; Das GC; Kumar-M P; Chaluvashetty SB; Bhujade H; Gulati A; Kalra N
Eur Radiol; 2021 Oct; 31(10):7725-7733. PubMed ID: 33786656
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic Performance of LI-RADS Treatment Response Algorithm for Hepatocellular Carcinoma: Adding Ancillary Features to MRI Compared with Enhancement Patterns at CT and MRI.
Park S; Joo I; Lee DH; Bae JS; Yoo J; Kim SW; Lee JM
Radiology; 2020 Sep; 296(3):554-561. PubMed ID: 32692297
[TBL] [Abstract][Full Text] [Related]
38. Hepatic sarcomatoid carcinoma: magnetic resonance imaging evaluation by using the liver imaging reporting and data system.
Seo N; Kim MJ; Rhee H
Eur Radiol; 2019 Jul; 29(7):3761-3771. PubMed ID: 30859282
[TBL] [Abstract][Full Text] [Related]
39. LI-RADS Version 2017 versus Version 2018: Diagnosis of Hepatocellular Carcinoma on Gadoxetate Disodium-enhanced MRI.
Lee SM; Lee JM; Ahn SJ; Kang HJ; Yang HK; Yoon JH
Radiology; 2019 Sep; 292(3):655-663. PubMed ID: 31310175
[TBL] [Abstract][Full Text] [Related]
40. The Value of Contrast-Enhanced Ultrasound Liver Imaging Reporting and Data System in the Diagnosis of Hepatocellular Carcinoma: A Meta-Analysis.
Peng J; Zhang T; Wang H; Ma X
J Ultrasound Med; 2022 Jun; 41(6):1537-1547. PubMed ID: 34617296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
